These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31427592)
1. Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy. Veeramachaneni R; Walker T; Revil T; Weck A; Badescu D; O'Sullivan J; Higgins C; Elliott L; Liloglou T; Risk JM; Shaw R; Hampson L; Hampson I; Dearden S; Woodwards R; Prime S; Hunter K; Parkinson EK; Ragoussis J; Thakker N Sci Rep; 2019 Aug; 9(1):11992. PubMed ID: 31427592 [TBL] [Abstract][Full Text] [Related]
2. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751 [TBL] [Abstract][Full Text] [Related]
4. Distinct effects of alcohol consumption and smoking on genetic alterations in head and neck carcinoma. Urashima M; Hama T; Suda T; Suzuki Y; Ikegami M; Sakanashi C; Akutsu T; Amagaya S; Horiuchi K; Imai Y; Mezawa H; Noya M; Nakashima A; Mafune A; Kato T; Kojima H PLoS One; 2013; 8(11):e80828. PubMed ID: 24278325 [TBL] [Abstract][Full Text] [Related]
5. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival. Lin SC; Lin LH; Yu SY; Kao SY; Chang KW; Cheng HW; Liu CJ Carcinogenesis; 2018 Dec; 39(11):1320-1330. PubMed ID: 30102337 [TBL] [Abstract][Full Text] [Related]
6. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
7. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer. Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563 [TBL] [Abstract][Full Text] [Related]
8. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance. Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017 [TBL] [Abstract][Full Text] [Related]
9. The Proteomic Landscape of Growth Factor Signaling Networks Associated with Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295 [TBL] [Abstract][Full Text] [Related]
11. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive. Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas. Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J Cells; 2019 Apr; 8(4):. PubMed ID: 31010087 [TBL] [Abstract][Full Text] [Related]
13. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma. Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090 [TBL] [Abstract][Full Text] [Related]
14. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Loughran O; Malliri A; Owens D; Gallimore PH; Stanley MA; Ozanne B; Frame MC; Parkinson EK Oncogene; 1996 Aug; 13(3):561-8. PubMed ID: 8760298 [TBL] [Abstract][Full Text] [Related]
15. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061 [TBL] [Abstract][Full Text] [Related]
16. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma. Shah PA; Huang C; Li Q; Kazi SA; Byers LA; Wang J; Johnson FM; Frederick MJ Cells; 2020 Dec; 9(12):. PubMed ID: 33322834 [TBL] [Abstract][Full Text] [Related]
17. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR; Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175 [TBL] [Abstract][Full Text] [Related]
18. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835 [TBL] [Abstract][Full Text] [Related]
19. Delineating an epigenetic continuum in head and neck cancer. Worsham MJ; Stephen JK; Chen KM; Havard S; Shah V; Gardner G; Schweitzer VG Cancer Lett; 2014 Jan; 342(2):178-84. PubMed ID: 22388100 [TBL] [Abstract][Full Text] [Related]
20. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis. Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]